Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E28.86 EPS (ttm)5.66 Insider Own0.10% Shs Outstand2.63B Perf Week-1.12%
Market Cap438.82B Forward P/E15.67 EPS next Y10.42 Insider Trans0.00% Shs Float2.63B Perf Month-3.95%
Income15.12B PEG3.87 EPS next Q2.26 Inst Own69.30% Short Float0.58% Perf Quarter0.86%
Sales84.21B P/S5.21 EPS this Y-4.20% Inst Trans-0.74% Short Ratio2.14 Perf Half Y6.97%
Book/sh25.02 P/B6.53 EPS next Y9.46% ROA8.90% Target Price186.65 Perf Year16.84%
Cash/sh9.17 P/C17.82 EPS next 5Y7.45% ROE23.60% 52W Range133.65 - 173.65 Perf YTD3.81%
Dividend4.24 P/FCF42.95 EPS past 5Y-0.30% ROI14.60% 52W High-5.86% Beta0.72
Dividend %2.60% Quick Ratio1.00 Sales past 5Y3.30% Gross Margin66.40% 52W Low22.32% ATR1.99
Employees134500 Current Ratio1.30 Sales Q/Q7.90% Oper. Margin20.70% RSI (14)43.55 Volatility0.96% 1.22%
OptionableYes Debt/Eq0.51 EPS Q/Q12.70% Profit Margin17.90% Rel Volume0.45 Prev Close163.37
ShortableYes LT Debt/Eq0.46 EarningsApr 20 BMO Payout70.40% Avg Volume7.09M Price163.48
Recom1.90 SMA20-1.00% SMA50-1.69% SMA2003.99% Volume181,791 Change0.07%
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Jun-25-21 09:18AM  
09:08AM  
09:00AM  
07:12AM  
06:10AM  
06:00AM  
Jun-24-21 04:48PM  
03:50PM  
02:00PM  
01:29PM  
11:48AM  
10:31AM  
09:51AM  
08:10AM  
05:35AM  
Jun-23-21 03:39PM  
01:48PM  
10:52AM  
09:37AM  
05:39AM  
Jun-22-21 08:00PM  
06:32AM  
Jun-21-21 05:45PM  
02:44PM  
01:05PM  
12:21PM  
11:46AM  
09:53AM  
09:50AM  
09:29AM  
Jun-20-21 03:00PM  
07:03AM  
06:35AM  
05:55AM  
Jun-18-21 02:04PM  
01:19PM  
Jun-17-21 04:47PM  
04:30PM  
03:07PM  
02:20PM  
11:00AM  
10:27AM  
06:00AM  
06:00AM  
Jun-16-21 04:06PM  
01:48PM  
12:44PM  
09:57AM  
09:38AM  
06:04AM  
06:00AM  
05:48AM  
Jun-15-21 07:47PM  
03:20PM  
02:53PM  
11:49AM  
08:17AM  
06:20AM  
06:00AM  
04:46AM  
04:38AM  
03:07AM  
Jun-14-21 05:45PM  
04:48PM  
04:41PM  
02:47PM  
01:47PM  
12:56PM  
11:45AM  
11:23AM  
10:26AM  
08:52AM  
08:28AM  
07:35AM  
07:32AM  
06:20AM  
05:52AM  
02:34AM  
Jun-13-21 09:29AM  
05:48AM  
05:18AM  
Jun-12-21 06:06AM  
Jun-11-21 07:22PM  
05:35PM  
03:26PM  
03:20PM  
02:27PM  
01:42PM  
12:52PM  
12:42PM  
12:18PM  
11:54AM  
11:51AM  
11:28AM  
11:20AM  
10:51AM  
10:15AM  
09:17AM  
07:23AM  
06:40AM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM